🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lung Cancer, Small Cell

A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC NCT06754644Phase 31 site📍 Jinan Qilu Pharmaceutical Co., Ltd. · Tests: QL2107, Pemetrexed, Carboplatin, Keytruda® Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） NCT07388771n/a2 sites📍 Wuhan📍 Hangzhou Qian Chu Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC NCT06739928Phase 21 site📍 Guangzhou Guangzhou Institute of Respiratory Disease · Tests: Irinotecan liposome (II) combined with adebrelimab and carboplatin, etoposide combined with adebrelimab and carboplatin Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer NCT07070011n/a1 site📍 Shanghai Shanghai Chest Hospital of Shanghai Jiao Tong University · Tests: EC/EP + ICIs Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review A Real World Study of Ensartinib in Advanced ALK-positive NSCLC NCT05498064n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Ensartinib Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress T… A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site📍 Hangzhou Zeng Jian · Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites📍 Guangzhou📍 Chengdu Guangdong Association of Clinical Trials · Tests: Sintilimab Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC NCT06162221Phase 1, Phase 298 sites📍 Gilbert📍 Duarte📍 Irvine Revolution Medicines, Inc. · Tests: RMC-6291, RMC-6236, Pembrolizumab, Cisplatin, Carboplatin Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors NCT06107608NA1 site📍 Brussels Jules Bordet Institute · Tests: FAPI PET/CT TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: TILs（Tumor Infiltrating Lymphocytes） A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) NCT07373964Phase 21 site📍 Shenyang China Medical University, China · Tests: Chidamide Tablets； PD-L1 Inhibitor (as per chosen drug's prescribing information)；Carboplatin； Etoposide ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs NCT06775743Phase 21 site📍 Shanghai Fudan University · Tests: ORIENT-31 regimen, SBRT To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer NCT07195084NA1 site📍 Hefei Anhui Provincial Cancer Hospital · Tests: Hypervision proton surgery A Study of JMT203 in Patients With Cancer Cachexia NCT06868849Phase 1, Phase 21 site📍 Zhejiang Shanghai JMT-Bio Inc. · Tests: JMT203 Injection, JMT203 Injection A Phase I Study of CFT8919 in Patients With Advanced NSCLC NCT06641609Phase 11 site📍 Hangzhou Betta Pharmaceuticals Co., Ltd. · Tests: Dose-Escalation (Phase Ia) CFT8919 capsule, Dose-Expansion (Phase Ib) CFT8919 capsule, Cohort-Expansion (Phase Ic) CFT8… Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites📍 Ferrol📍 Alicante📍 Badalona Fundación GECP · Tests: Durvalumab The Effect of Beta-glucan in Non-Small Cell Lung Cancer NCT00682032NA1 site📍 Louisville University of Louisville · Tests: beta-glucan Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer NCT07189455Phase 31 site📍 Shanghai Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Tests: ZG006, Topotecan Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer NCT06926179n/a4 sites📍 Beijing📍 Beijing📍 Hohhot Peking University Cancer Hospital & Institute · Tests: neoadjuvant immunotherapy A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer NCT06954246Phase 31 site📍 Shanghai Qilu Pharmaceutical Co., Ltd. · Tests: MHB088C for Injection, Topotecan, Irinotecan, Paclitaxel A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation. NCT05967689Phase 280 sites📍 Birmingham📍 Duarte📍 Boston Taiho Oncology, Inc. · Tests: TAS6417, CYP Cocktail, Transporter Cocktail Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT07761910Phase 21 site📍 Indianapolis Indiana University · Tests: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients NCT06481813NA4 sites📍 Angers📍 Nantes📍 Rennes Nantes University Hospital · Tests: Blood Sampling (2*8mL Tubes), PBMC Sampling (1*8mL Tubes), Paxgene Sampling, Extended biopsies of tumor lesions Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer NCT06527898Phase 1, Phase 21 site📍 Hefei Anhui Provincial Hospital · Tests: hypofractionated radiotherapy with immunotherapy Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer NCT06833632n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases NCT05033691NA1 site📍 Jerusalem Hadassah Medical Organization · Tests: Stereotactic surgery
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy